Key Takeaways CJC-1295 plus Ipamorelin is not FDA approved: There is no approved CJC-1295/Ipamorelin brand, finished drug, or human therapeutic indication
Olfactory dysfunction, including parosmia, has been associated with liraglutide use 46 , likely reflecting GLP-1R-mediated modulation of odor-evoked insulin secretion and foraging behaviors in the olfactory bulb 51,52
Lamos EM, Malek R, Davis SN
Similarly, long-term treatment with the carnitine inhibitor meldonium can induce adaptive cardioprotective effects by altering energy metabolic pathways [299]
When it comes to anti-doping and clean sport we are in serious trouble when giant retailers like Amazon are once again some of the largest purveyors of performance enhancing drugs on earth